Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical resultsG Bertelli, D Dini, G B Forno, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|January 1, 1982
[Influence of alcohol intake and smoking on plasma HDL cholesterol in active and sedentary subjects]S Bertolini, E Reggiani, R Balestreri, et al.
Breast Cancer Research and Treatment|December 1, 1988
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levelsG Bertelli, P Pronzato, D Amoroso, et al.
American Journal of Clinical Oncology|December 1, 1989
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancerP Pronzato, E Campora, D Amoroso, et al.
Breast Cancer Research and Treatment|November 1, 1990
Megestrol acetate: phase II study of a single daily administration in advanced breast cancerP Pronzato, F Brema, D Amoroso, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2001
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2014
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysisM Aapro, V Moebus, U Nitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2010
Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?L Del Mastro, C Bighin, G Bini, et al.
American Journal of Clinical Oncology|February 1, 1993
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensityP Pronzato, L Miglietta, A Rubagotti, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical resultsG Bertelli, D Dini, G B Forno, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|January 1, 1982
[Influence of alcohol intake and smoking on plasma HDL cholesterol in active and sedentary subjects]S Bertolini, E Reggiani, R Balestreri, et al.
Breast Cancer Research and Treatment|December 1, 1988
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levelsG Bertelli, P Pronzato, D Amoroso, et al.
American Journal of Clinical Oncology|December 1, 1989
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancerP Pronzato, E Campora, D Amoroso, et al.
Breast Cancer Research and Treatment|November 1, 1990
Megestrol acetate: phase II study of a single daily administration in advanced breast cancerP Pronzato, F Brema, D Amoroso, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2001
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2014
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysisM Aapro, V Moebus, U Nitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2010
Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?L Del Mastro, C Bighin, G Bini, et al.
American Journal of Clinical Oncology|February 1, 1993
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensityP Pronzato, L Miglietta, A Rubagotti, et al.
Pageof 13